Hypereosinophilic syndrome (Q101690): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Síndrome hipereosinofílica (SHE) constitui um grupo raro e heterogêneo de transtornos, definido como eosinofilia sanguínea persistente e acentuada (maior que 1,5 x 10 [9a potência]/L por mais de seis meses consecutivos, associada a evidências de danos a órgãos induzidos por eosinófilos, quando outras causas de hipereosinofilia, como transtornos alérgicos, parasitários e malignos, foram excluídos._x000D_ _x000D_ Informações adicionais: As apresentações clínicas variam, desde envolvimento cutâneo benigno até manifestações graves, como endomiocardiofibrose e tromboembolismo. Os subtipos incluem a associação com a síndrome de Churg-Strauss (granulomatose eosinofílica com poliangiite), neoplasias mieloides, variante linfocítica de células T e endocardite de Loeffler, assim como a idiopática. | |||
| description / en | description / en | ||
Hypereosinophilic syndrome (HES) constitute a rare and heterogeneous group of disorders, defined as persistent and marked blood eosinophilia (greater than 1.5 x 10[9th power]/L for more than six consecutive months, associated with evidence of eosinophil-induced organ damage, where other causes of hypereosinophilia such as allergic, parasitic, and malignant disorders have been excluded. Additional information: Clinical presentations vary, from benign cutaneous involvement to severe manifestations such as endomyocardial fibrosis and thromboembolism. Subtypes include the association with Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis), myeloid neoplasms, T cell lymphocytic variant and Loeffler's endocarditis, as well as idiopathic. | |||
Revision as of 18:31, 16 August 2026
Hypereosinophilic syndrome (HES) constitute a rare and heterogeneous group of disorders, defined as persistent and marked blood eosinophilia (greater than 1.5 x 10[9th power]/L for more than six consecutive months, associated with evidence of eosinophil-induced organ damage, where other causes of hypereosinophilia such as allergic, parasitic, and malignant disorders have been excluded. Additional information: Clinical presentations vary, from benign cutaneous involvement to severe manifestations such as endomyocardial fibrosis and thromboembolism. Subtypes include the association with Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis), myeloid neoplasms, T cell lymphocytic variant and Loeffler's endocarditis, as well as idiopathic.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_110429919 |
||
| English | Hypereosinophilic syndrome |
Hypereosinophilic syndrome (HES) constitute a rare and heterogeneous group of disorders, defined as persistent and marked blood eosinophilia (greater than 1.5 x 10[9th power]/L for more than six consecutive months, associated with evidence of eosinophil-induced organ damage, where other causes of hypereosinophilia such as allergic, parasitic, and malignant disorders have been excluded. Additional information: Clinical presentations vary, from benign cutaneous involvement to severe manifestations such as endomyocardial fibrosis and thromboembolism. Subtypes include the association with Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis), myeloid neoplasms, T cell lymphocytic variant and Loeffler's endocarditis, as well as idiopathic. |
